A Preliminary Survey on the Oral Manifestation of COVID-19 in the First and Second Waves in Bhubaneswar, City of Odisha, India

Authors

  • Ruchi Bhuyan IMS & SUM Hospital, Siksha ‘O’ Anusandhan deemed to be Uni., Bhubaneswar
  • Sanat Kumar Bhuyan IMS & SUM Hospital, Siksha ‘O’ Anusandhan deemed to be Uni., Bhubaneswar
  • Jatindra Nath Mohanty IMS & SUM Hospital, Siksha ‘O’ Anusandhan deemed to be Uni., Bhubaneswar
  • Nihar Ranjan Panda IMS & SUM Hospital, Siksha ‘O’ Anusandhan deemed to be Uni., Bhubaneswar
  • Varsha Bhuyan IMS & SUM Hospital, Siksha ‘O’ Anusandhan deemed to be Uni., Bhubaneswar
  • Priyadarshini Ojha IMS & SUM Hospital, Siksha ‘O’ Anusandhan deemed to be Uni., Bhubaneswar
  • Pallavi Priyadarshini IMS & SUM Hospital, Siksha ‘O’ Anusandhan deemed to be Uni., Bhubaneswar
  • Gangadhar Sahoo IMS & SUM Hospital, Siksha ‘O’ Anusandhan deemed to be Uni., Bhubaneswar

DOI:

https://doi.org/10.55489/njcm.130520221617

Keywords:

COVID-19, Epidemiology, Oral Features, Dental Diseases, Oral Health

Abstract

Background: In both waves of COVID-19 infections, loss of taste was noted in a disproportionately high number of individuals. However, there is a considerable risk of dental disease during and after COVID -19 infections.

Aim: Our aim here is to study the oral manifestation of the COVID -19 infections and make a comparison of the severity of presentation in the second wave with the first wave among the general population in Bhubaneswar, city of Odisha, India.

Methods: A detailed online questionnaire was developed focusing on the oral manifestation during both the waves using Google forms.

Results: Out of a total of 380 RT PCR positive cases, 91/169 and 167/211 cases with oral manifestation were obtained in the first and second waves, respectively. We found 41 (24.26 %) in the first wave and 63 (29.85 %) in the second wave of patients with oral manifestations over the age of 50. Patients receiving oxygen or using a ventilator were found to be 15 (8.9 %) in the first wave and 59 (28%) in the second wave.

Conclusion: This is the first study to evaluate the correlation of oral infection with COVID 19 in different waves. This difference could be correlated with the virulence of viruses with mutated strains.

References

Ali I. COVID-19: Are We Ready for the Second Wave? Disaster Med Public Health Prep. 2020 Oct;14(5):e16-e18. Epub 2020 May 7. DOI: https://doi.org/10.1017/dmp.2020.149 PMid:32379015 PMCid:PMC7239772 DOI: https://doi.org/10.1017/dmp.2020.149

Jain VK, Iyengar KP, Vaishya R. Differences between First wave and Second wave of COVID-19 in India. Diabetes Metab Syndr. 2021 May-Jun;15(3):1047-1048. Epub 2021 May 8. PMID: 33992554; PMCID: PMC8106236. DOI: https://doi.org/10.1016/j.dsx.2021.05.009 PMid:33992554 PMCid:PMC8106236

Moona AA, Islam MR. Mucormycosis or black fungus is a new fright in India during covid-19 pandemic: Associated risk factors and actionable items. Public Health Pract (Oxf). 2021 Nov;2:100153. Epub 2021 Jun 21. DOI: https://doi.org/10.1016/j.puhip.2021.100153 PMid:34179859 PMCid:PMC8215889 DOI: https://doi.org/10.1016/j.puhip.2021.100153

COVID-19 Dashboard, Available from: https://www.mygov.in/covid-19 (Accessed on 20 July 2021).

Mahajan P, Kaushal J. Epidemic Trend of COVID-19 Transmission in India During Lockdown-1 Phase. J Community Health. 2020 Dec;45(6):1291-1300. DOI: https://doi.org/10.1007/s10900-020-00863-3 PMid:32578006 PMCid:PMC7309423 DOI: https://doi.org/10.1007/s10900-020-00863-3

Kar, S. K., Ransing, R., Arafat, S., & Menon, V. Second wave of COVID-19 pandemic in India: Barriers to effective governmental response. (2021). EClinicalMedicine, 36, 100915. DOI: https://doi.org/10.1016/j.eclinm.2021.100915 PMid:34095794 PMCid:PMC8164526 DOI: https://doi.org/10.1016/j.eclinm.2021.100915

Lazarevic I, Pravica V, Miljanovic D, Cupic M. Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far? Viruses. 2021 Jun 22;13(7):1192. DOI: https://doi.org/10.3390/v13071192 PMid:34206453 PMCid:PMC8310325 DOI: https://doi.org/10.3390/v13071192

Jain VK, Iyengar KP, Vaishya R. Differences between First wave and Second wave of COVID-19 in India. Diabetes & metabolic syndrome. 2021 May 8. DOI: https://doi.org/10.1016/j.dsx.2021.05.009 PMid:33992554 PMCid:PMC8106236 DOI: https://doi.org/10.1016/j.dsx.2021.05.009

Kamble P, Daulatabad V, John N, John J. Synopsis of symptoms of COVID-19 during second wave of the pandemic in India. Hormone Molecular Biology and Clinical Investigation. 2021 Dec 7. DOI: https://doi.org/10.1515/hmbci-2021-0043 PMid:34881534 DOI: https://doi.org/10.1515/hmbci-2021-0043

Iranmanesh B, Khalili M, Amiri R, Zartab H, Aflatoonian M. Oral manifestations of COVID-19 disease: A review article. Dermatol Ther. 2021 Jan;34(1):e14578. Epub 2020 Dec 13. DOI: https://doi.org/10.1111/dth.14578 PMID: 33236823; PMCID: PMC7744903

Al-Khatib A. Oral manifestations in COVID-19 patients. Oral Dis. 2021 Apr;27 Suppl 3:779-780. Epub 2020 Jul 7. DOI: https://doi.org/10.1111/odi.13477 PMid:32521067 PMCid:PMC7307069 DOI: https://doi.org/10.1111/odi.13477

Iranmanesh B, Khalili M, Amiri R, Zartab H, Aflatoonian M. Oral manifestations of COVID-19 disease: A review article. Dermatol Ther. 2021 Jan;34(1):e14578. Epub 2020 Dec 13. PMID: 33236823; PMCID: PMC7744903. DOI: https://doi.org/10.1111/dth.14578 PMCid:PMC7744903 DOI: https://doi.org/10.1111/dth.14578

Amorim Dos Santos J, Normando AGC, Carvalho da Silva RL, De Paula RM, Cembranel AC, Santos-Silva AR, Guerra ENS. Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations? Int J Infect Dis. 2020 Aug;97:326-328. Epub 2020 Jun 9. DOI: https://doi.org/10.1016/j.ijid.2020.06.012 PMid:32526392 PMCid:PMC7280113 DOI: https://doi.org/10.1016/j.ijid.2020.06.012

Dziedzic A, Wojtyczka R. The impact of coronavirus infectious disease 19 (COVID‐19) on oral health. Oral diseases. 2021 Apr;27:703-6. DOI: https://doi.org/10.1111/odi.13359 PMid:32304276 PMCid:PMC7264805 DOI: https://doi.org/10.1111/odi.13359

Godinho GV, Paz AL, de Araújo Gomes EP, Garcia CL, Volpato LE. Extensive hard palate hyperpigmentation associated with chloroquine use. British journal of clinical pharmacology. 2020 Nov;86(11):2325-7. DOI: https://doi.org/10.1111/bcp.14313 PMid:32307721 PMCid:PMC7264573 DOI: https://doi.org/10.1111/bcp.14313

Mehra MR, Ruschitzka F, Patel AN. Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet. 2020 Jun 13;395(10240):1820. DOI: https://doi.org/10.1016/S0140-6736(20)31324-6 DOI: https://doi.org/10.1016/S0140-6736(20)31324-6

Martín Carreras-Presas C, Amaro Sánchez J, López-Sánchez AF, Jané-Salas E, Somacarrera Pérez ML. Oral vesiculobullous lesions associated with SARS-CoV- 2 infection. Oral Dis 2020;(May), DOI: https://doi.org/10.1111/odi.13382 PMid:32369674 PMCid:PMC7267423 DOI: https://doi.org/10.1111/odi.13382

Putra BE, Adiarto S, Dewayanti SR, Juzar DA. Viral exanthem with "pin and needles sensation" on extremities of COVID-19 patient. Int J Infect Dis 2020;(May), DOI: https://doi.org/10.1016/j.ijid.2020.05.020 PMid:32437936 PMCid:PMC7207113 DOI: https://doi.org/10.1016/j.ijid.2020.05.020

Botros N, Iyer P, Ojcius DM. Is there an association between oral health and severity of COVID-19 complications?. biomedical journal. 2020 Aug 1;43(4):325-7. DOI: https://doi.org/10.1016/j.bj.2020.05.016 PMid:32713780 PMCid:PMC7258848 DOI: https://doi.org/10.1016/j.bj.2020.05.016

Brian Z, Weintraub JA. Peer Reviewed: Oral Health and COVID-19: Increasing the Need for Prevention and Access. Preventing chronic disease. 2020;17.DOI: https://doi.org/10.5888/pcd17.200266 PMid:32790606 PMCid:PMC7458118 DOI: https://doi.org/10.5888/pcd17.200266

Farook FF, Nuzaim MN, Ababneh KT, Alshammari A, Alkadi L. COVID-19 pandemic: oral health challenges and recommendations. European journal of dentistry. 2020 Nov 24.doi: 10.1055/s-0040-1718641. DOI: https://doi.org/10.1055/s-0040-1718641 PMid:33233004 PMCid:PMC7775230 DOI: https://doi.org/10.1055/s-0040-1718641

Ren YF, Rasubala L, Malmstrom H, Eliav E. Dental care and oral health under the clouds of COVID-19. JDR Clinical & Translational Research. 2020 Jul;5(3):202-10. DOI: https://doi.org/10.1177/2380084420924385 PMid:32330078 DOI: https://doi.org/10.1177/2380084420924385

Marchini L, Ettinger RL. COVID‐19 pandemics and oral health care for older adults. Special Care in Dentistry. 2020 May;40(3):329. DOI: https://doi.org/10.1111/scd.12465 PMid:32391586 PMCid:PMC7272993 DOI: https://doi.org/10.1111/scd.12465

Kamel AH, Basuoni A, Salem ZA, AbuBakr N. The impact of oral health status on COVID-19 severity, recovery period and C-reactive protein values. British dental journal. 2021 Feb 24:1-7. DOI: https://doi.org/10.1038/s41415-021-2656-1 PMid:33627848 PMCid:PMC7904030 DOI: https://doi.org/10.1038/s41415-021-2656-1

Downloads

Published

2022-05-31

How to Cite

1.
Bhuyan R, Bhuyan SK, Mohanty JN, Panda NR, Bhuyan V, Ojha P, Priyadarshini P, Sahoo G. A Preliminary Survey on the Oral Manifestation of COVID-19 in the First and Second Waves in Bhubaneswar, City of Odisha, India. Natl J Community Med [Internet]. 2022 May 31 [cited 2022 Jul. 5];13(05):294-7. Available from: https://njcmindia.com/index.php/file/article/view/1617

Issue

Section

Original Research Articles